You are here

olumiant

Trial finds Lilly’s Olumiant could treat type 1 diabetes

Pharmaphorum

Thu, 12/7/23 - 11:00 am

type 1 diabetes

Concert persuades FDA to keep breakthrough tag for alopecia therapy despite Lilly's arrival

Fierce Biotech

Wed, 02/15/23 - 10:48 am

Concert Pharmaceuticals

alopecia areata

breakthrough therapy

Eli Lilly wins FDA approval for first-ever treatment for hair loss caused by autoimmunity

Stat

Mon, 06/13/22 - 09:49 pm

alopecia areata

Eli Lilly revs up immunology engine as Olumiant cruises toward coveted alopecia green light

Fierce Pharma

Thu, 05/19/22 - 12:05 pm

FDA approves new indication for drug to treat severe COVID-19

Beckers Hospital Review

Thu, 05/12/22 - 10:51 pm

UK Recovery trial confirms Covid benefit for Olumiant

EP Vantage

Mon, 03/7/22 - 09:55 am

clinical trials

Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA

Fierce Pharma

Fri, 01/28/22 - 11:47 am

Two new drugs added to WHO list of COVID-19 therapies

Pharmaforum

Mon, 01/17/22 - 10:26 am

Vir Biotechnololgy

Eli Lilly touts long-term safety data for Olumiant amid classwide scrutiny on JAK meds

Fierce Pharma

Wed, 11/10/21 - 09:39 pm

Could This Be the Next Blockbuster Indication for Eli Lilly?

Motley Fool

Thu, 10/21/21 - 10:37 am

alopecia areata

clinical trials

Lilly, Incyte: Olumiant Superior to Placebo in Scalp Hair Regrowth as Early as 24 Weeks

Marketwatch

Fri, 10/1/21 - 10:51 am

alopecia areata

AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA

Yahoo/Benzinga

Sun, 07/18/21 - 09:45 pm

atopic dermatitis

Lilly's Olumiant Found to Lower Pain In Late-Stage Rheumatoid Arthritis Trial

Yahoo/Benzinga

Thu, 06/3/21 - 11:03 am

clinical trials

rheumatoid arthritis

Series of JAK inhibitor delays may signal an upcoming FDA adcomm

Endpoints

Thu, 04/8/21 - 11:10 am

FDA pushes eczema decision for Eli Lilly's Olumiant, Pfizer's abrocitinib back 3 months — raising more questions for the JAK class

Endpoints

Wed, 04/7/21 - 10:30 am

AI uncovers Eli Lilly's rheumatoid arthritis drug Olumiant as potential Alzheimer's treatment

Fierce Biotech

Mon, 03/8/21 - 10:42 am

artificial intelligence

Alzheimer's disease

Physicians express skepticism about Lilly arthritis drug OK'd as COVID-19 treatment

Beckers Hospital Review

Tue, 12/8/20 - 10:33 am

Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus remdesivir combo

Endpoints

Thu, 11/19/20 - 11:09 pm

Emergency Use Authorization

Eli Lilly and Gilead’s combination cuts COVID-19 recovery time

Pharmaforum

Fri, 10/9/20 - 10:52 am

Gilead Sciences

clinical trials

Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters

MedCity News

Wed, 09/16/20 - 07:47 pm

Gilead Sciences

Pages